Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
8.72
-0.03 (-0.34%)
At close: Oct 17, 2025, 4:00 PM EDT
8.80
+0.08 (0.92%)
After-hours: Oct 17, 2025, 7:01 PM EDT
Alvotech Market Cap
Alvotech has a market cap or net worth of $2.73 billion as of October 17, 2025. Its market cap has decreased by -26.43% in one year.
Market Cap
2.73B
Enterprise Value
3.85B
1-Year Change
-26.43%
Ranking
Category
Stock Price
$8.72
Market Cap Chart
Since November 9, 2020, Alvotech's market cap has increased from $304.69M to $2.73B, an increase of 795.84%. That is a compound annual growth rate of 55.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 2.73B | -31.60% |
| Dec 31, 2024 | 3.99B | 30.92% |
| Dec 29, 2023 | 3.05B | 22.59% |
| Dec 30, 2022 | 2.49B | 705.34% |
| Dec 31, 2021 | 308.75M | -5.82% |
| Dec 31, 2020 | 327.81M | 7.59% |
| Nov 9, 2020 | 304.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |